Peptides for Anxiety: Selank, Semax and the Evidence
Peptides for anxiety have no FDA-approved option. No peptide is on the NIMH list of anxiety medicines. openFDA has no label for selank or semax. The main human evidence is two small selank studies, in 60 and 62 patients. Both compared selank with other anxiety drugs, not with a placebo.
Sources: National Institute of Mental Health, Mental Health Medications health topic page (retrieved October 2026), anti-anxiety medications section. Supports: what anti-anxiety medicines do; SSRIs and SNRIs; benzodiazepine tolerance and dependence; buspirone taken daily for 3 to 4 weeks; Medvedev VE et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2014. PMID 25176261. Supports: 60 patients; selank compared with phenazepam; anxiolytic and mild nootropic effects; Zozulia AA et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2008. PMID 18454096. Supports: 62 patients; anxiolytic effects of both drugs similar; antiasthenic and psychostimulant effects
Short answer
- Is there a peptide approved for anxiety?
- None that we found. MedlinePlus says the main care for anxiety disorders is talk therapy, medicine, or both.
- Which peptide has the most anxiety research?
- Selank. Two studies compared it with other drugs. Neither had a placebo group. The FDA says it lacks key safety facts on selank acetate in people.
- What about semax and oxytocin?
- We found no anxiety trial of semax. For nasal oxytocin, a 2025 review calls the evidence mixed.
Sources: MedlinePlus, Anxiety (US National Library of Medicine health topic page, retrieved October 2026). Supports: the definition of anxiety; main treatments are talk therapy, medicines or both; support groups and stress management; US FDA web page, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (page dated 22 April 2026, retrieved October 2026). Supports: the selank acetate entry (missing human safety information) and the semax entry (immune reaction risk); Moshfeghinia R et al. Exploring the efficacy of intranasal oxytocin for anxiety and stress-related disorders through fMRI study: a systematic review. BMC Pharmacology and Toxicology, 10 October 2025. PMID 41074229. Supports: evidence for clinical efficacy remains mixed
Is Any Peptide Approved for Anxiety?
No peptide is approved for anxiety in the sources we checked. The approved care is talk therapy and medicines that are not peptides.
MedlinePlus is run by the US National Library of Medicine. It says the main care for anxiety disorders is psychotherapy (talk therapy), medicine, or both. NIMH says anxiety medicines help ease symptoms. Examples are panic attacks and extreme fear and worry. Its medicine page also covers SSRIs and SNRIs. These are medicines used for depression.
Selank and semax are not on that list. We searched openFDA and found no label for either one. On the FDA's own site, they show up on one page. That page lists raw ingredients that may be risky when pharmacies mix drugs (compounding).
Sources: MedlinePlus, Anxiety (US National Library of Medicine health topic page, retrieved October 2026). Supports: the definition of anxiety; main treatments are talk therapy, medicines or both; support groups and stress management; National Institute of Mental Health, Mental Health Medications health topic page (retrieved October 2026), anti-anxiety medications section. Supports: what anti-anxiety medicines do; SSRIs and SNRIs; benzodiazepine tolerance and dependence; buspirone taken daily for 3 to 4 weeks; US FDA web page, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (page dated 22 April 2026, retrieved October 2026). Supports: the selank acetate entry (missing human safety information) and the semax entry (immune reaction risk)
Does Selank Work for Anxiety?
Two small studies say selank eased anxiety about as well as the drugs it was tested against. Neither study had a placebo group. That limits what they can show.
The 2014 study: selank vs phenazepam
This study compared selank with phenazepam, another anxiety drug. It looked at how well each eased anxiety and how well people put up with it. It had 60 patients. They had phobic anxiety or somatoform disorders, as coded in ICD-10. The summary reports strong anti-anxiety effects of selank. It also reports mild nootropic effects, meaning effects on thinking.
The 2008 study: two drugs in 62 patients
This study looked at 62 patients. They had generalized anxiety disorder (GAD) or neurasthenia. The summary says both drugs eased anxiety about the same. It adds that selank also eased tiredness (an antiasthenic effect) and had a stimulant effect.
What these studies cannot tell you
A placebo group lets a trial see what the drug itself does. Without one, you cannot tell the drug apart from getting better anyway. We searched PubMed and ClinicalTrials.gov. We found no placebo trial of selank for anxiety. So these studies show selank and the other drugs did about the same. They do not show how much of that was selank itself. More on the selank profile.
Sources: Medvedev VE et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2014. PMID 25176261. Supports: 60 patients; selank compared with phenazepam; anxiolytic and mild nootropic effects; Zozulia AA et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2008. PMID 18454096. Supports: 62 patients; anxiolytic effects of both drugs similar; antiasthenic and psychostimulant effects
How Selank May Act in the Brain
Lab work suggests selank may act on the brain's GABA system. A 2018 review looked at how selank works at the molecule level. It says selank changed GABA binding as a positive allosteric modulator.
A positive allosteric modulator does not switch a receptor on by itself. It turns up how strongly the receptor answers its normal signal. This was a lab result. It hints at how selank might work. It does not show an effect in people.
Does Semax Help With Anxiety?
We found no trial of semax for anxiety. Semax often comes up next to selank, but the anxiety studies above are about selank only.
The FDA says pharmacy-made (compounded) drugs with semax may cause immune reactions for some routes. Its reason is that the peptide can clump together. It can also carry impurities. For how the two compare on other uses, see semax vs selank and the semax profile.
Nasal Oxytocin and Anxiety
Oxytocin is a peptide hormone. Researchers have sprayed it into the nose to study anxiety. A 2025 review says the evidence that it works is still mixed.
That review looked at brain scans (fMRI). It asked how nasal oxytocin changes the brain in anxiety and stress disorders. A change on a scan is not the same as people feeling less anxious. For more on how peptides are given through the nose, see our guide to peptide nasal sprays.
Peptides vs Approved Anxiety Treatments
The gap in evidence is wide. The medicines NIMH names have known effects and known risks. The peptides have small comparison studies or none.
| Option | Status | What the source says |
|---|---|---|
| SSRIs and SNRIs | Medicines named on the NIMH medication page | Used for depression; NIMH covers them on the same page |
| Benzodiazepines | Named by NIMH as an anxiety medicine | NIMH: long use may lead to tolerance or even dependence |
| Buspirone | Named by NIMH as an anxiety medicine | NIMH: must be taken every day for 3 to 4 weeks to reach full effect |
| Selank | No FDA label found | Two studies comparing it with other drugs (60 and 62 patients); FDA lacks human safety information |
| Semax | No FDA label found | No anxiety trial found; FDA flags immune reaction risk for compounded forms |
| Nasal oxytocin | Studied for anxiety, not approved for it in our sources | A 2025 review: the evidence that it works is still mixed |
The NIMH medication page notes two timing and safety points worth knowing. On buspirone, NIMH says:
Buspirone: taken every day for 3 to 4 weeks to reach its full effect
Disclaimer: this is information from a public health agency. It is not a recommendation. Choices about any medicine belong with a licensed clinician.
On benzodiazepines, NIMH says taking them for a long time may lead to tolerance. That means the drug works less well. It may even lead to dependence.
Sources: National Institute of Mental Health, Mental Health Medications health topic page (retrieved October 2026), anti-anxiety medications section. Supports: what anti-anxiety medicines do; SSRIs and SNRIs; benzodiazepine tolerance and dependence; buspirone taken daily for 3 to 4 weeks; Medvedev VE et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2014. PMID 25176261. Supports: 60 patients; selank compared with phenazepam; anxiolytic and mild nootropic effects; Zozulia AA et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2008. PMID 18454096. Supports: 62 patients; anxiolytic effects of both drugs similar; antiasthenic and psychostimulant effects; US FDA web page, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (page dated 22 April 2026, retrieved October 2026). Supports: the selank acetate entry (missing human safety information) and the semax entry (immune reaction risk); Moshfeghinia R et al. Exploring the efficacy of intranasal oxytocin for anxiety and stress-related disorders through fMRI study: a systematic review. BMC Pharmacology and Toxicology, 10 October 2025. PMID 41074229. Supports: evidence for clinical efficacy remains mixed
Anxiety vs an Anxiety Disorder
Anxiety is a common feeling; an anxiety disorder is when it does not go away. MedlinePlus describes anxiety as a feeling of fear, dread and uneasiness.
NIMH says an anxiety disorder is more than worry or fear now and then. For people with one, the anxiety does not go away. It shows up in many places. And it can get worse over time. These disorders are common. NIMH says about a third of US teens and adults have one at some point in life.
Sources: MedlinePlus, Anxiety (US National Library of Medicine health topic page, retrieved October 2026). Supports: the definition of anxiety; main treatments are talk therapy, medicines or both; support groups and stress management; National Institute of Mental Health, Anxiety Disorders health topic page (dated December 2024, retrieved October 2026). Supports: what an anxiety disorder is; about a third of US adolescents and adults
Other Support for Anxiety
Beyond therapy and medicine, MedlinePlus says two more things may help. One is support groups. The other is ways to manage stress.
For other options people ask about, see supplements for anxiety. For peptides talked about for focus and memory, see peptides for brain function.
This page describes research. It does not tell anyone to start, change or stop a treatment. Anxiety that does not go away is worth raising with a doctor or mental health professional.
Common Questions
Is there a peptide approved for anxiety?+
We found none. NIMH lists anxiety medicines such as benzodiazepines and buspirone. None of them is a peptide. openFDA has no label for selank or semax. MedlinePlus says the main care for anxiety disorders is talk therapy, medicine, or both.
Does selank work for anxiety?+
Two small studies compared selank with other anxiety drugs. One had 60 patients. It reported strong anti-anxiety effects and mild effects on thinking. The other had 62 patients. It found both drugs eased anxiety about the same. We found no trial with a placebo group. So we do not know how much of the effect came from selank itself.
Is selank safe?+
Its safety in people is not well known. The FDA says it lacks key safety facts about selank acetate given to people. The two study summaries we read do not list side effects.
Does semax help with anxiety?+
We found no trial of semax for anxiety. The FDA says pharmacy-made (compounded) semax may cause immune reactions for some routes. It gives two reasons: the peptide can clump, and it can carry impurities.
Does nasal oxytocin help anxiety?+
It is being studied. A 2025 review looked at how nasal oxytocin changes brain activity in anxiety and stress disorders. It said the evidence that it works is still mixed.
What is the difference between anxiety and an anxiety disorder?+
MedlinePlus says anxiety is a feeling of fear, dread and unease. NIMH says an anxiety disorder is more than worry now and then. The anxiety does not go away. It shows up in many places. And it can get worse over time.
Sources: MedlinePlus, Anxiety (US National Library of Medicine health topic page, retrieved October 2026). Supports: the definition of anxiety; main treatments are talk therapy, medicines or both; support groups and stress management; National Institute of Mental Health, Anxiety Disorders health topic page (dated December 2024, retrieved October 2026). Supports: what an anxiety disorder is; about a third of US adolescents and adults; National Institute of Mental Health, Mental Health Medications health topic page (retrieved October 2026), anti-anxiety medications section. Supports: what anti-anxiety medicines do; SSRIs and SNRIs; benzodiazepine tolerance and dependence; buspirone taken daily for 3 to 4 weeks; Medvedev VE et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2014. PMID 25176261. Supports: 60 patients; selank compared with phenazepam; anxiolytic and mild nootropic effects; Zozulia AA et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova, 2008. PMID 18454096. Supports: 62 patients; anxiolytic effects of both drugs similar; antiasthenic and psychostimulant effects; US FDA web page, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (page dated 22 April 2026, retrieved October 2026). Supports: the selank acetate entry (missing human safety information) and the semax entry (immune reaction risk); Moshfeghinia R et al. Exploring the efficacy of intranasal oxytocin for anxiety and stress-related disorders through fMRI study: a systematic review. BMC Pharmacology and Toxicology, 10 October 2025. PMID 41074229. Supports: evidence for clinical efficacy remains mixed
Related reading
This guide is for educational purposes only and is not medical advice. It describes what public health agencies, published studies and the FDA report about anxiety and about selank, semax and oxytocin. It is not an endorsement or an instruction to use any compound. Selank and semax are not FDA-approved medicines. Talk to a qualified healthcare professional before making any decision about your health.